Cargando…
Enhancing antibody patent protection using epitope mapping information
As the $100B therapeutic monoclonal antibody (mAb) market continues to grow, developers of therapeutic mAbs increasingly face the need to strengthen patent protection of their products and enforce their patents in courts. In view of changes in the patent law landscape, patent applications are strate...
Autores principales: | Deng, Xiaoxiang, Storz, Ulrich, Doranz, Benjamin J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5825199/ https://www.ncbi.nlm.nih.gov/pubmed/29120697 http://dx.doi.org/10.1080/19420862.2017.1402998 |
Ejemplares similares
-
Mapping Antibody Epitopes of the Avian H5N1 Influenza Virus
por: Yen, Hui-Ling, et al.
Publicado: (2009) -
Broadly Protective Neuraminidase-Based Influenza Vaccines and Monoclonal Antibodies: Target Epitopes and Mechanisms of Action
por: Abbadi, Nada, et al.
Publicado: (2023) -
Insights into the IgG heavy chain engineering patent landscape as applied to IgG4 antibody development
por: Dumet, Christophe, et al.
Publicado: (2019) -
Patent pooling to increase access to essential medicines
por: Burrone, Esteban, et al.
Publicado: (2019) -
Trends in worldwide nanotechnology patent applications: 1991 to 2008
por: Dang, Yan, et al.
Publicado: (2009)